In the News January 8, 2019

Business Monitor Online | Mylan Launches Mesalamine Generic in US

Alston & Bird is noted for representing Mylan Pharmaceuticals Inc. in a drug patent dispute with Shire Development LLC.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement